CIK 0001739410
- Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851083789
- Phone
- +1 203-859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,608
- in 1 filing
Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Lieber Jonathan I Chief Financial Officer | Option exercise | +7,124 | $14.88 | $106K | 44,139 |
| 2026-11-02 | Lieber Jonathan I Chief Financial Officer | Option exercise · Option (Right to Buy) | −7,124 | 0 | ||
| 2026-10-29 | Lieber Jonathan I Chief Financial Officer | Option exercise | +7,875 | $14.88 | $117K | 23,426 |
| 2026-10-29 | Lieber Jonathan I Chief Financial Officer | Option exercise | +13,589 | $6.08 | $83K | 37,015 |
| 2026-10-29 | Lieber Jonathan I Chief Financial Officer | Option exercise · Option (Right to Buy) | −7,875 | 0 | ||
| 2026-10-29 | Lieber Jonathan I Chief Financial Officer | Option exercise · Option (Right to Buy) | −13,589 | 0 | ||
| 2026-10-27 | Lieber Jonathan I Chief Financial Officer | Sale | −599 | $16.04 | $10K | 15,551 |
| 2026-10-26 | Lieber Jonathan I Chief Financial Officer | Grant or award | +2,500 | 16,150 | ||
| 2026-10-09 | Lieber Jonathan I Chief Financial Officer | Option exercise | +3,910 | $6.08 | $24K | 13,650 |
| 2026-10-09 | Lieber Jonathan I Chief Financial Officer | Option exercise · Option (Right to Buy) | −3,910 | 0 | ||
| 2026-09-29 | Lieber Jonathan I Chief Financial Officer | Option exercise | +5,000 | $6.08 | $30K | 9,740 |
| 2026-09-29 | Lieber Jonathan I Chief Financial Officer | Option exercise · Option (Right to Buy) | −5,000 | 0 | ||
| 2026-02-23 | Lieber Jonathan I Chief Financial Officer | Sale | −789 | $5.06 | $4K | 4,115 |
| 2026-02-18 | Lieber Jonathan I Chief Financial Officer | Grant or award | +2,500 | 4,904 | ||
| 2025-02-14 | Lieber Jonathan I Chief Financial Officer | Grant or award · Option (Right to Buy) | +180,000 | 180,000 | ||
| 2024-02-15 | Lieber Jonathan I Chief Financial Officer | Grant or award · Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-03-14 | Lieber Jonathan I See Remarks | Purchase | +5,000 | $5.21 | $26K | 5,000 |
| 2023-02-01 | Lieber Jonathan I See Remarks | Grant or award · Option (Right to Buy) | +240,000 | 240,000 |
Page 1 of 1 · 18 trades